These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31623310)

  • 21. Design and evaluation of peptide-18-targeted nanoliposomes constructed by poly(2-oxazoline)-DOPE for doxorubicin delivery.
    Devrim B; Bolat ZB; Telci D; Şahin F; Gulyuz S; Ozkose UU; Yilmaz O; Bozkır A
    J Microencapsul; 2021 Aug; 38(5):285-297. PubMed ID: 33853478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A facile surface modification strategy for fabrication of fluorescent silica nanoparticles with the aggregation-induced emission dye through surface-initiated cationic ring opening polymerization.
    Huang L; Yang S; Chen J; Tian J; Huang Q; Huang H; Wen Y; Deng F; Zhang X; Wei Y
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():270-278. PubMed ID: 30423709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F; Peterson D; Hughes J; Milich DR
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gold nanoparticle-decorated reduced-graphene oxide targeting anti hepatitis B virus core antigen.
    Abd Muain MF; Cheo KH; Omar MN; Amir Hamzah AS; Lim HN; Salleh AB; Tan WS; Ahmad Tajudin A
    Bioelectrochemistry; 2018 Aug; 122():199-205. PubMed ID: 29660648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered.
    Pyrski M; Rugowska A; Wierzbiński KR; Kasprzyk A; Bogusiewicz M; Bociąg P; Samardakiewicz S; Czyż M; Kurpisz M; Pniewski T
    Vaccine; 2017 Oct; 35(42):5714-5721. PubMed ID: 28917537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel self-assembled polymeric micelles from partially hydrolysed poly(2-ethyl-2-oxazoline)-co-PEI-b-PCL block copolymer as non-viral vectors for plasmid DNA in vitro transfection.
    Kara A; Ozturk N; Esendagli G; Ozkose UU; Gulyuz S; Yilmaz O; Telci D; Bozkir A; Vural I
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S264-S273. PubMed ID: 30032650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Label Matters: μPET Imaging of the Biodistribution of Low Molar Mass
    Glassner M; Palmieri L; Monnery BD; Verbrugghen T; Deleye S; Stroobants S; Staelens S; Wyffels L; Hoogenboom R
    Biomacromolecules; 2017 Jan; 18(1):96-102. PubMed ID: 28064503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and Functional Characterizations of Cancer Targeting Nanoparticles Based on Hepatitis B Virus Capsid.
    Heo Y; Jeong H; Yoo Y; Yun JH; Ryu B; Cha YJ; Lee BR; Jeon YE; Kim J; Jeong S; Jo E; Woo JS; Lee J; Cho HS; Lee W
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native agarose gel electrophoresis and electroelution: A fast and cost-effective method to separate the small and large hepatitis B capsids.
    Yoon KY; Tan WS; Tey BT; Lee KW; Ho KL
    Electrophoresis; 2013 Jan; 34(2):244-53. PubMed ID: 23161478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticulate delivery of irinotecan active metabolite (SN38) in murine colorectal carcinoma through conjugation to poly (2-ethyl 2-oxazoline)-b-poly (L-glutamic acid) double hydrophilic copolymer.
    Salmanpour M; Yousefi G; Samani SM; Mohammadi S; Anbardar MH; Tamaddon A
    Eur J Pharm Sci; 2019 Aug; 136():104941. PubMed ID: 31136788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative immunogenicity of hepatitis B virus core and E antigens.
    Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
    J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(2-oxazoline)s One-Pot Polymerization and Surface Coating: From Synthesis to Antifouling Properties Out-Performing Poly(ethylene oxide).
    Svoboda J; Sedláček O; Riedel T; Hrubý M; Pop-Georgievski O
    Biomacromolecules; 2019 Sep; 20(9):3453-3463. PubMed ID: 31329428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
    Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
    J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus peptide inhibitors: solution structures and interactions with the viral capsid.
    Muhamad A; Ho KL; Rahman MB; Tejo BA; Uhrín D; Tan WS
    Org Biomol Chem; 2015 Jul; 13(28):7780-9. PubMed ID: 26100394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleolar localization of human hepatitis B virus capsid protein.
    Ning B; Shih C
    J Virol; 2004 Dec; 78(24):13653-68. PubMed ID: 15564475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. POZylation: a new approach to enhance nanoparticle diffusion through mucosal barriers.
    Mansfield ED; Sillence K; Hole P; Williams AC; Khutoryanskiy VV
    Nanoscale; 2015 Aug; 7(32):13671-9. PubMed ID: 26214263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.